News Archive

Caplacizumab Update

By Sydney Kodatsky | Tuesday, July 2, 2019 - 12:00am

July 2019: Cablivi will shortly be reviewed (by CADTH and INESSS), and recommendations made to Canadian decision makers regarding approval for use and funding. All those diagnosed with TTP are encouraged to help provide the patient perspective to aid decision makers by taking part in the upcoming community survey.
Support Groups

Fall 2018 Ohio TTP & aHUS Support Group Meeting

By Sydney Kodatsky | Thursday, November 15, 2018 - 10:18am

The Ohio State University TTP/aHUS face-to-face meeting was made available to non-local participants to join virtually. On Wednesday November 7th, Dr. Cataland presented a great layman explanation about the role of the ADAMTS13 enzyme in TTP. In addition, he thoughtfully answered questions from both the face-to-face and virtual audiences about TTP triggers, treatments, side effects and more. On an exciting note, he explained the role of a new drug called caplacizumab.

Researcher's Work is Published

By Sydney Kodatsky | Wednesday, September 26, 2018 - 9:25am

Answering TTP Foundation provided research grant funding to support Dr. Long Zheng which has resulted in two research papers on TTP. Together we are furthering the understanding and coming closer to a targeted treatment for TTP. Congratulations Dr. Long Zheng! And congratulations to all supporters of the Answering TTP Foundation.

hTTP Study Recruiting

By Sydney Kodatsky | Tuesday, July 24, 2018 - 9:57am

A healthcare research firm is recruiting patients who have been diagnosed with hereditary (inherited) thrombotic thrombocytopenic purpura (hTTP). hTTP represents about 1% of  TTP cases and is characterized by inherited deficiency or abnormality of the ADAMTS 13 enzyme.

For more information and for participation instructions click here.

Fundraising Initiatives

2018 Chance for Change Game Night

By Sydney Kodatsky | Sunday, May 6, 2018 - 7:19pm

The 9th Annual Chance for Change raised $200,000 on April 21, 2018. Guests were thrilled by our new venue, our wide selection of silent auction items, the fun games, exciting raffles, stunning entertainment and delicious food. 

Listen to the feedback from our guests ----

Research Outcomes

By Sydney Kodatsky | Friday, May 4, 2018 - 2:02pm

The Answering TTP Foundation's Board of Directors has received impact statements from two Principal Investigators that have completed their Foundation funded grants. The results are encouraging. A patient-led organization plays a vital role in the quest to conquer TTP. Congratulations to our researchers and to all those who support the Foundation.

More information about these research grant outcomes has been uploaded to each grant information page,

Pages